Moderna Gets U.S. FDA Approval For Influenza Vaccine Mflusiva For Use In Adults 50 Years And Older
MRNA•FDA approves Mflusiva for adults 50 and older
Moderna Inc. said it expects supply of its influenza vaccine Mflusiva to be available in select retailers in the coming weeks.
Moderna said it has received U.S. FDA approval for the influenza vaccine Mflusiva for use in adults 50 years and older.
